Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
A Rashidi, M Hamadani, MJ Zhang, HL Wang… - Blood …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …
[HTML][HTML] Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia …
D Salvatore, M Labopin, A Ruggeri, G Battipaglia… - …, 2018 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …
[HTML][HTML] Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute …
Y Wang, DH Liu, LP Xu, KY Liu, H Chen… - Biology of Blood and …, 2011 - Elsevier
The outcomes of an historic comparison of 117 consecutive, high-risk, acute leukemia
patients undergoing hematopoietic stem cell transplantation (HSCT) from HLA-mismatched …
patients undergoing hematopoietic stem cell transplantation (HSCT) from HLA-mismatched …
Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a …
G Battipaglia, A Boumendil, M Labopin… - Bone marrow …, 2019 - nature.com
Refractory or relapsed acute myeloid leukemia (R/R-AML) has poor prognosis. Allogeneic
hematopoietic stem-cell transplantation (HSCT) may provide cure in this scenario. We …
hematopoietic stem-cell transplantation (HSCT) may provide cure in this scenario. We …
[HTML][HTML] Comparison of outcomes after peripheral blood haploidentical versus matched unrelated donor allogeneic hematopoietic cell transplantation in patients with …
A Rashidi, JF DiPersio, P Westervelt, R Vij… - Biology of blood and …, 2016 - Elsevier
Recent studies comparing allogeneic hematopoietic cell transplantation (HCT) using HLA-
matched unrelated donors (MUD) versus HLA-haploidentical donors in patients with acute …
matched unrelated donors (MUD) versus HLA-haploidentical donors in patients with acute …
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Y Wang, QF Liu, LP Xu, KY Liu… - Blood, The Journal …, 2015 - ashpublications.org
The effects of HLA-identical sibling donor (ISD) hematopoietic stem cell transplantation
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first …
S Yu, F Huang, Y Wang, Y Xu, T Yang, Z Fan, R Lin… - Leukemia, 2020 - nature.com
This study aimed to investigate graft-versus-leukemia (GVL) of haploidentical donor (HID)
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …
Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia
W Saber, S Opie, JD Rizzo, MJ Zhang… - Blood, The Journal …, 2012 - ashpublications.org
Approximately one-third of patients with an indication for hematopoietic cell transplantation
(HCT) have an HLA-matched related donor (MRD) available to them. For the remaining …
(HCT) have an HLA-matched related donor (MRD) available to them. For the remaining …
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …
MS Tallman, GW Dewald, S Gandham… - Blood, The Journal …, 2007 - ashpublications.org
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable …
V Gupta, MS Tallman, W He, BR Logan… - Blood, The Journal …, 2010 - ashpublications.org
We compared the outcomes of unrelated donor (URD, n= 358) with human leukocyte
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …